TABLE 1.
Designation, sequence, origin, and fluorescent labeling of the peptides used in the study
The boldface amino acids in the sequence represent d-amino acids. AMP, antimicrobial peptide.
| Designation | Protein of origin | Fluorescent labeling | Sequence |
|---|---|---|---|
| ISLAD | HIV-1 gp41 | SNKSLEQIWNHTTWMEWD | |
| ISLAD-Rho | HIV-1 gp41 | Rho | Rho-SNKSLEQIWNHTTWMEWD |
| ISLAD l-CM | HIV-1 gp41 | WNHTTWMEWD | |
| ISLAD l-CM-Rho | HIV-1 gp41 | Rho | Rho-WNHTTWMEWD |
| ISLAD d-CM | HIV-1 gp41 | WNHTTWMEWD | |
| ISLAD d-CM-Rho | HIV-1 gp41 | Rho | Rho-WNHTTWMEWD |
| Scrambled ISLAD l-CM | HIV-1 gp41 | WTHWMENWTD | |
| Control peptide | HIV-1 gp41 | TTAVPWNASW | |
| TCR l-CP-NBD | Mouse TCRα | NBD | NBD-GLRILLLKV |
| TCR l-CP2G-NBD | Mouse TCRα | NBD | NBD-GLGILLLGV |
| TCR d-CP2G-Rho | Mouse TCRα | Rho | Rho-GLGILLLGV |
| AMP-Rho | Synthetic antimicrobial | Rho | Rho-KLKLLKLLKLLKLLK |
| LL37-Rho | Human cathelicidin | Rho | Rho-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| MOG35–55 | Mouse myelin | MEVGWYRSPFSRVVHLYRNGK |